The medical letter on drugs and therapeutics/The medical letter
The Medical Letter, Inc.
About the journal
The medical letter on drugs and therapeutics/The medical letter is a journal published by The Medical Letter, Inc. in United States. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- The Medical Letter, Inc.
- ISSN
- 1523-2859 · 0025-732X
- Country
- United States
- Access
- Not open access / not declared
- Official website
- http://secure.medicalletter.org/medicalletter
Index listings
- MEDLINE · 1965-01-01
- PUBMED · 1965-01-01
- Indexing
- MEDLINE · PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
491
Last recorded publication year
2026
h-index
7
i10-index
3
From OpenAlex open data (CC0).
Editorial & policy3
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 0%
- ORCID iDs in current deposits
- 0%
Identity & continuity3
- Alternate titles
- Medical letter
- Source type
- journal
- NLM unique ID (PubMed)
- 2985240R
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Diabetes Treatment and Management
- Diabetes Treatment and Management
- Pharmaceutical studies and practices
- Pharmaceutical studies and practices
- Respiratory viral infections research
- Lung Cancer Treatments and Mutations
- CAR-T cell therapy research
- Lung Cancer Treatments and Mutations
Show all subjects (50)
- CAR-T cell therapy research
- Respiratory viral infections research
- SARS-CoV-2 and COVID-19 Research
- Asthma and respiratory diseases
- SARS-CoV-2 and COVID-19 Research
- Pharmacology and Obesity Treatment
- Colorectal Cancer Treatments and Studies
- Asthma and respiratory diseases
- Pharmacology and Obesity Treatment
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Urticaria and Related Conditions
- Influenza Virus Research Studies
- Urticaria and Related Conditions
- Alzheimer's disease research and treatments
- Chronic Myeloid Leukemia Treatments
- Chronic Lymphocytic Leukemia Research
- Cancer Immunotherapy and Biomarkers
- Chronic Myeloid Leukemia Treatments
- Influenza Virus Research Studies
- Chronic Lymphocytic Leukemia Research
- Dermatology and Skin Diseases
- Lymphoma Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Dermatology and Skin Diseases
- Advanced Breast Cancer Therapies
- Opioid Use Disorder Treatment
- Immunodeficiency and Autoimmune Disorders
- Lymphoma Diagnosis and Treatment
- Advanced Breast Cancer Therapies
- Cancer Treatment and Pharmacology
- Opioid Use Disorder Treatment
- Migraine and Headache Studies
- Alzheimer's disease research and treatments
- Cancer Treatment and Pharmacology
- Bladder and Urothelial Cancer Treatments
- Monoclonal and Polyclonal Antibodies Research
- Attention Deficit Hyperactivity Disorder
- Migraine and Headache Studies
- Glaucoma and retinal disorders
- Bladder and Urothelial Cancer Treatments
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ